IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Schering-Plough to Buy Akzo’s Pharma Unit

1:43 PM MDT | March 21, 2007 | Alex Scott and Kerri Walsh

Akzo Nobel says it has agreed to sell its pharmaceuticals business Organon BioSciences (OBS) to Schering-Plough for €11 billion ($14.5 billion). The companies expect the deal to be completed in the second half, following regulatory approval. The divestiture would provide Akzo with extra cash, which has rekindled some expectations that Akzo plans to bid for ICI, media reports say. The deal will fill a gap in Schering-Plough’s late-stage drug development pipeline by adding five compounds in Phase III development and several “promising projects in...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa